#Brazil #Menlo Park #Subtle Medical #SubtleHD™ #Brasil

Subtle Medical Expands into Latin America

Subtle Medical, a front-runner in AI-driven medical imaging solutions, has made significant strides with its recent announcement revealing that its flagship product, SubtleHD™, is now commercially available in Brazil. Gaining regulatory approval from ANVISA marks a monumental achievement not just for the company but also for Brazilian healthcare, which is often challenged by limited resources and aging technology.

Enhancing MRI Imaging with AI

SubtleHD™ is a powerful deep learning technology that has previously gained recognition for its ability to enhance the quality of MRI images substantially. This product has already secured FDA clearance and CE marking, showcasing its efficacy and safety in clinical settings. The technology enables MRI scanners to produce images with better quality and up to 80% faster scan times under certain conditions, which can significantly improve patient experiences in crucial diagnostic scenarios.

In Brazil, the healthcare landscape currently features around 14.5 MRI machines for every million citizens, trailing slightly behind the worldwide average of 20.7. Given the country's population and the rising demand for MRI services, it's estimated that Brazil requires approximately 30,000 MRI exams per million people each year, translating into roughly 6 million MRI scans overall. The introduction of SubtleHD™ will play a critical role in addressing these growing demands while also enhancing the quality of care provided in hospitals and imaging centers across the nation.

Addressing Infrastructure Challenges

Brazilian healthcare institutions often experience prolonged wait times for MRI scans due to high patient volumes and limited access to modern imaging technologies. The healthcare systems are further strained by budget constraints, which complicate the acquisition of new MRI machines. With SubtleHD™, existing machines can be updated to perform at an enhanced capacity, therefore unlocking more scanning positions without the need for substantial capital investments in new equipment.

Features such as improved image quality on older MRI machines and faster examination times make this technology an appealing solution to optimize operational workflows and alleviate patient backlogs. Coupled with vendor-neutral compatibility, SubtleHD™ fits seamlessly into the current healthcare infrastructure, ensuring a smoother transition and implementation process.

Collaboration with Local Distributors

Subtle Medical has established a partnership with Hospiline to facilitate its entry into the Brazilian market. Hospiline is an established distributor of medical technologies in Latin America, known for bringing advanced healthcare solutions to clinics and hospitals. This collaboration aims to empower healthcare providers and enhance their ability to deliver exceptional patient care through innovation.

Josh Gurewitz, Chief Commercial Officer at Subtle Medical, expressed optimism about this expansion, stating, "We're excited to introduce SubtleHD™ in Brazil. With Hospiline's support, imaging providers across the country can now harness AI to bridge infrastructure gaps, elevate diagnostic confidence, and improve productivity—all while enhancing patient care."

Summary

Subtle Medical's launch of SubtleHD™ in Brazil marks a transformative moment for the country’s healthcare sector. By integrating advanced artificial intelligence into existing imaging systems, the company not only promises to improve diagnostic processes but also enhance patient care outcomes, all without the need for new hardware investments. This move symbolizes Subtle Medical’s commitment to expanding accessible healthcare solutions throughout Latin America, aiming to meet the pressing demands of a growing population while delivering high-quality medical services.

For more information about Subtle Medical and its innovative products, interested parties can visit www.subtlemedical.com.